📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. (2021)

First Author: Reis TAR

Attributed to: VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exppara.2020.108059

PubMed Identifier: 33338468

Publication URI: http://europepmc.org/abstract/MED/33338468

Type: Journal Article/Review

Volume: 221

Parent Publication: Experimental parasitology

ISSN: 0014-4894